Yu‐Lin Su

1.7k total citations
33 papers, 1.3k citations indexed

About

Yu‐Lin Su is a scholar working on Immunology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Yu‐Lin Su has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Biomedical Engineering and 9 papers in Molecular Biology. Recurrent topics in Yu‐Lin Su's work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (7 papers) and Immune Cell Function and Interaction (5 papers). Yu‐Lin Su is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (7 papers) and Immune Cell Function and Interaction (5 papers). Yu‐Lin Su collaborates with scholars based in Taiwan, United States and China. Yu‐Lin Su's co-authors include Shang‐Hsiu Hu, Chi‐Shiun Chiang, Marcin Kortylewski, Lian Zhou, Shaowei Huang, Xia Luo, Yanyang Li, Shuvomoy Banerjee, Wei Cheng and Zengfeng Pan and has published in prestigious journals such as Journal of Clinical Investigation, Nano Letters and Blood.

In The Last Decade

Yu‐Lin Su

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Lin Su Taiwan 18 503 438 278 257 208 33 1.3k
Zhirong Zhong China 24 766 1.5× 350 0.8× 345 1.2× 199 0.8× 134 0.6× 59 1.7k
Preethi Korangath United States 21 697 1.4× 431 1.0× 324 1.2× 152 0.6× 135 0.6× 42 1.5k
Xiao Xu China 21 615 1.2× 475 1.1× 306 1.1× 164 0.6× 123 0.6× 56 1.3k
Tianjiao Zhao China 19 453 0.9× 523 1.2× 182 0.7× 159 0.6× 373 1.8× 32 1.4k
Fengming You China 24 589 1.2× 452 1.0× 216 0.8× 138 0.5× 120 0.6× 94 1.4k
Goutam Dey India 24 716 1.4× 253 0.6× 349 1.3× 148 0.6× 80 0.4× 46 1.7k
Xu Song China 20 630 1.3× 505 1.2× 487 1.8× 130 0.5× 157 0.8× 57 1.4k
Meng Jia China 19 482 1.0× 427 1.0× 220 0.8× 223 0.9× 130 0.6× 36 1.4k
Worapol Ngamcherdtrakul United States 17 560 1.1× 372 0.8× 290 1.0× 200 0.8× 157 0.8× 26 1.3k
Yin Dou China 21 612 1.2× 584 1.3× 524 1.9× 301 1.2× 311 1.5× 34 1.8k

Countries citing papers authored by Yu‐Lin Su

Since Specialization
Citations

This map shows the geographic impact of Yu‐Lin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Lin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Lin Su more than expected).

Fields of papers citing papers by Yu‐Lin Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Lin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Lin Su. The network helps show where Yu‐Lin Su may publish in the future.

Co-authorship network of co-authors of Yu‐Lin Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Lin Su. A scholar is included among the top collaborators of Yu‐Lin Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Lin Su. Yu‐Lin Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Jiayu, Yu‐Lin Su, Yu‐Chen Lin, et al.. (2025). All-in-one and on-demand wound dressing based on a deep eutectic solvent ionic gel. Chemical Engineering Journal. 515. 163849–163849. 1 indexed citations
3.
Wang, Dongfang, Yu‐Lin Su, Jérémy Hall, et al.. (2024). Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice. Molecular Therapy — Nucleic Acids. 35(3). 102268–102268. 2 indexed citations
4.
Huang, Shaowei, Xiaojing Wang, Xueqian Xie, et al.. (2022). Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3. Journal of Ethnopharmacology. 299. 115652–115652. 36 indexed citations
5.
Luo, Shuang, Shaowei Huang, Xiaojing Wang, et al.. (2022). Emodin targeting the colonic metabolism via PPARγ alleviates UC by inhibiting facultative anaerobe. Phytomedicine. 104. 154106–154106. 33 indexed citations
6.
Wang, Xiaojing, Shaowei Huang, Meiling Zhang, et al.. (2022). Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice. Journal of Ethnopharmacology. 302(Pt B). 115919–115919. 62 indexed citations
7.
Li, Yanyang, Xiaojing Wang, Yu‐Lin Su, et al.. (2021). Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s. Acta Pharmacologica Sinica. 43(6). 1495–1507. 166 indexed citations
8.
Moreira, Dayson, Sagus Sampath, Haejung Won, et al.. (2020). Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity. Journal of Clinical Investigation. 131(2). 71 indexed citations
9.
Su, Yu‐Lin, Chia‐Hsien Hsu, Chi‐Shiun Chiang, et al.. (2020). Rabies virus glycoprotein-amplified hierarchical targeted hybrids capable of magneto-electric penetration delivery to orthotopic brain tumor. Journal of Controlled Release. 321. 159–173. 25 indexed citations
10.
Zhang, Zhuoran, Xingli Zhao, Dongfang Wang, et al.. (2020). Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy. Molecular Therapy. 29(3). 1214–1225. 8 indexed citations
11.
Liu, Chang, Yanyang Li, Yanping Chen, et al.. (2020). Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis. Mediators of Inflammation. 2020. 1–19. 51 indexed citations
12.
Quader, Sabina, Xueying Liu, Kazuko Toh, et al.. (2020). Supramolecularly enabled pH- triggered drug action at tumor microenvironment potentiates nanomedicine efficacy against glioblastoma. Biomaterials. 267. 120463–120463. 44 indexed citations
13.
Su, Yu‐Lin, Piotr Swiderski, Guido Marcucci, & Marcin Kortylewski. (2019). Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo. Methods in molecular biology. 1974. 141–150. 4 indexed citations
14.
Su, Yu‐Lin, Xiuli Wang, Mati Mann, et al.. (2019). Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo. Blood. 135(3). 167–180. 97 indexed citations
15.
16.
Zhang, Zhuoran, Dayson Moreira, Yu‐Lin Su, et al.. (2018). Inhibition of Survival Signaling in B-Cell Lymphoma Using TLR9-Targeted Delivery of NF-Kb Decoy Oligodeoxynucleotides in Vitro and in Vivo. Experimental Hematology. 64. S113–S113. 1 indexed citations
17.
Zhao, Xingli, Zhuoran Zhang, Dayson Moreira, et al.. (2018). B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors. Molecular Therapy. 26(3). 695–707. 26 indexed citations
18.
Su, Yu‐Lin, Ya-Hui Chang, Shiou‐Ru Tzeng, et al.. (2016). Importance of the C-terminal histidine residues of Helicobacter pylori GroES for Toll-like receptor 4 binding and interleukin-8 cytokine production. Scientific Reports. 6(1). 37367–37367. 5 indexed citations
19.
Lin, Chien‐Ting, et al.. (2016). Dual‐Targeted Photopenetrative Delivery of Multiple Micelles/Hydrophobic Drugs by a Nanopea for Enhanced Tumor Therapy. Advanced Functional Materials. 26(23). 4169–4179. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhirong Zhong Breakdown of academic impact, for papers by Preethi Korangath Breakdown of academic impact, for papers by Xiao Xu Breakdown of academic impact, for papers by Tianjiao Zhao Breakdown of academic impact, for papers by Fengming You Breakdown of academic impact, for papers by Goutam Dey Breakdown of academic impact, for papers by Xu Song Breakdown of academic impact, for papers by Meng Jia Breakdown of academic impact, for papers by Worapol Ngamcherdtrakul Breakdown of academic impact, for papers by Yin Dou
Rankless by CCL
2026